A team headed by Claude Perreault, Director of IRIC's Immunobiology Research Unit and Professor at the Faculty of Medicine at Université de Montréal, has identified novel tumor antigens that could ...
The need for effective adjuvant therapies and evidence that the immune system plays a prominent role in the development and progression of melanoma (Curiel-Lewandrowski & Demierre, 2000) have led to ...
Chimeric antigen receptor (CAR) therapies utilize engineered receptors that are able to redirect immune cells to identify and destroy cancer cells that express a specific antigen. At present, CAR-T ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback